iPSC-Derived Cardiomyocytes: Advancing Cardiac Research & Drug Discovery
From KAb12. Oktober 20245 min
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are transforming cardiac research and drug discovery. Pioneered by Takahashi and Yamanaka, these cells are crucial for disease modeling and drug safety. Companies like NEXEL lead with innovations like the Cardiosight®-S platform. Despite challenges, advancements in hiPSC-CM maturity and organ-on-a-chip integration promise breakthroughs in personalized medicine.
Extracellular Vesicles (EVs) Explained: The Ultimate Guide to Exosome Research in 2024
From KAb01. Oktober 202410 min
Unlock the secrets of extracellular vesicles (EVs) and explore their groundbreaking role in cell communication, disease pathways, and targeted therapies. From cancer to heart disease, exosomes and microvesicles are revolutionizing personalized medicine and drug delivery, paving the way for innovative diagnostic and treatment strategies.
We use marketing cookies to measure the effectiveness of our advertisements. In addition, this data may be used to present relevant advertising content.
Web analytics service
Anbieter: Google Ireland Limited, Google Building Gordon House, 4 Barrow St, Dublin, D04 E5W5, Ireland
Data processing purposes: Analysis | Optimization
Technologies used: Cookies
Place of processing: European Union
Transfer to third countries: Worldwide
Data recipients: Alphabet Inc. | Google Ireland Limited | Google LLC
